Back to top
more

Endo International plc (ENDP)

(Delayed Data from NSDQ)

$8.20 USD

8.20
3,004,238

+0.48 (6.22%)

Updated May 3, 2019 04:00 PM ET

After-Market: $8.19 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Endo (ENDP) Q2 Earnings Beat Estimates, 2017 Guidance Cut

Endo (ENDP) beat second-quarter 2017 earnings and sales. However, revenues were down on a year over year basis due to generic competition adversely impacting the branded established products portfolio.

    What's in Store for BioDelivery (BDSI) This Earnings Season?

    BioDelivery Sciences International (BDSI) has been focusing on growth territories and expanding Bunavail's label. However, the extent to which these impact second-quarter results remains to be seen.

      What's in the Cards for Endo (ENDP) this Earnings Season?

      Endo International plc (ENDP) remains focused on providing updates on its restructuring efforts across the Generics product as well as its manufacturing facility network in Q2.

        Options Traders Expect Huge Moves in Endo International (ENDP) Stock

        Options Traders Expect Huge Moves in Endo International (ENDP) Stock on the back of its huge implied volatility

          Nektar's NKTR-181 Positive in Human Abuse Potential Study

          Positive top line results from an oral human abuse potential (HAP) study, evaluating the opioid analgesic candidate -- NKTR-181 -- to assess abuse potential compared with oxycodone, nudged up Nektar's (NKTR) shares.

            BioDelivery-Purdue Pharma Ink Marketing Deal for Pain Drug

            BioDelivery Sciences International, Inc. (BDSI) announced an exclusive partnership agreement with Purdue Pharma, a Canadian pharmaceutical company, for commercializing its pain drug Belbuca in Canada.

              Mallinckrodt to Pay $35M for Controlled Substances Probe

              Mallinckrodt plc (MNK) recently finalized the agreement which it had reached with the U.S. Drug Enforcement Administration (DEA) and the U.S. Attorneys' Offices (USAOs) for the Eastern District of Michigan and the Northern District of New York.

                Endo (ENDP) to Remove Opioid Pain Drug Opana ER from Market

                Endo International plc (ENDP) recently announced that it will withdraw opioid pain medication Opana ER (oxymorphone hydrochloride extended release) from the market following FDA's request in June.

                  BioDelivery Inks New Contract with CVS/Caremark, Shares Up

                  BioDelivery Sciences International, Inc. (BDSI) announced an agreement with CVS/Caremark to extend access to its pain management product Belbuca and opioid dependence product Bunavail through 2020.

                    Is Endo International (ENDP) a Great Stock for Value Investors?

                    Is Endo International a great pick from the value investor's perspective right now? Read on to know more.

                      Why Is Endo (ENDP) Down 4.7% Since the Last Earnings Report?

                      Endo (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                        Company News for June 12, 2017

                        Companies in the News are: DFT,DLR,ENDP,P,SIRI,LXRX

                          Endo Asked to Withdraw Pain Drug-Opana ER by FDA, Stock Down

                          Endo International plc (ENDP) received a huge setback when the FDA directed the company to voluntarily remove its opioid pain medication Opana ER (oxymorphone hydrochloride extended release) from the market over abuse concerns.

                            Intellipharmaceutics Announces Launch of Generic Seroquel XR

                            Intellipharmaceutics International Inc. (IPCI) announced the launch of a generic version of schizophrenia drug Seroquel XR by its marketing and distribution partner in the U.S, Mallinckrodt Public Limited Company

                              BioDelivery (BDSI) Q1 Earnings Beat Estimates, Stock Gains

                              BioDelivery Sciences International, Inc. (BDSI) reported earnings of 58 cents per share in the first quarter of 2017, which comfortably beat the Zacks Consensus Estimate of 9 cents.

                                Endo (ENDP) Beats on Q1 Earnings, Reaffirms '17 Guidance

                                Endo International plc's (ENDP) first-quarter 2017 earnings from continuing operations was $1.23 per share which topped the Zacks Consensus Estimate of $1.12. Earnings were also above the year-ago figure of $1.08.

                                  Madhu Goel headshot

                                  Endo (ENDP) Q1 Earnings Beat Estimates, Revenues in Line

                                  Endo surpassed first-quarter 2017 earnings. The company reported EPS of $1.23 while our consensus called for EPS of $1.12.

                                    4 Drug Stocks Poised to Beat this Earnings Season

                                    M&A and licensing deals as well as drug pricing issues are expected to remain in focus in 2017.

                                      What's in Store for BioDelivery (BDSI) this Earnings Season?

                                      BioDelivery Sciences International, Inc. (BDSI) is expected to report first-quarter 2017 results later this month. Last quarter, the company???s loss was wider than expected.

                                        BioMarin (BMRN) Posts Earnings in Q1, Sales Top, Stock Up

                                        BioMarin Pharmaceutical Inc. (BMRN) reported earnings of 3 cents per share in the first quarter of 2017.

                                          Is Endo (ENDP) Poised for a Beat This Earnings Season?

                                          Endo International plc (ENDP) is scheduled to report first-quarter 2017 results on May 9, before the opening bell.

                                            Arpita Dutt headshot

                                            Generic Drugmakers Tumble as Perrigo Discloses DoJ Search

                                            With Perrigo (PRGO) disclosing that DoJ search warrants were executed at its corporate offices, industry-wide pricing practices are back in focus.

                                              IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected

                                              IntelliPharmaCeutics International Inc. (IPCI) reported loss of 7 cents per share in the first quarter of 2017, narrower than both the Zacks Consensus Estimate of a loss of 8 cents and the year-ago loss of 9 cents per share.

                                                Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock?

                                                Options traders are pricing in a big move for Endo International (ENDP) shares as it has huge implied volatility.

                                                  Endo (ENDP) Reports Preliminary Results for First Quarter

                                                  Endo International plc (ENDP) recently announced preliminary results for first-quarter 2017.